Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Human medicines
Search for medicinal products
Search for packages
ATC tree
User manual
Print
ICATIBANT FRESENIUS
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1822924
Name of medicinal product:
ICATIBANT FRESENIUS
Active substances:
Icatibant
Estonian
,
English
,
Latin
ATC code:
B06AC02
Dosage form:
solution for injection in pre-filled syringe
Route of administration:
subcutaneous use
Strengh:
30mg 3ml
Amount in package:
3ml 3TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Icatibant Fresenius is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency.
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated February 8, 2022)
Package information leaflet (PIL):
EST
(last updated February 8, 2022)
Labelling:
(last updated February 8, 2022)
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Fresenius Kabi Polska Sp. z o.o.
Marketing authorization number:
1051822
Marketing authorization issued on:
February 8, 2022
Marketing authorization expires on:
February 8, 2027
Marketing authorization procedure type:
Decentralised
Prices
Reference price:
Under reference price:
Reference price of daily dose:
Entry/Changing date: October 30, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here